Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06394089

Effect of Degenerative Spondylolisthesis on the Clinical Outcome of Unilateral Biportal Endoscopy for Lumbar Spinal Stenosis: Study Protocol

A single-center, prospective cohort trial aims to provide stronger evidence regarding the impact of degenerative spondylolisthesis on the clinical outcome of unilateral biportal endoscopy for lumbar spinal stenosis

Recruiting

Interested in participating?

Request Info

Key information

Age range

50 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Beijing Friendship Hospital

Beijing, Beijing Municipality, 100050, China

Location status: Recruiting

Location contact

Xiang Li

PRINCIPAL_INVESTIGATOR

Yue Li

CONTACT

[email protected]

+86 10 6313 9006

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age range: 50-80 years
  • Diagnosis of LSS affecting 1-2 vertebral levels
  • Predominant manifestation of neurogenic intermittent claudication, with ineffective conservative treatment for at least 3 months
  • Presence of lumbar DS of less than grade II and absence of spine instability
  • Willingness to participate in the study and complete follow-up assessments.

Exclusion criteria

  • Diagnosis of isthmic lumbar spondylolisthesis or lumbar DS of grade ≥II
  • Evidence of instability at the affected vertebral level (intervertebral angle change > 15° and/or vertebral translation ≥ 4.5 mm in standing flexion-extension radiographs of the lumbar spine)
  • History of prior surgery at the affected vertebral level
  • Presence of scoliosis with a Cobb angle >20º
  • Presence of other conditions affecting the lumbar spine (infection, tumor, fracture, neurological diseases, and others)
  • Medical disorders that preclude surgical tolerance
  • Participation in other clinical research projects related to the treatment of lumbar spinal stenosis.

Treatment and study plan

Primary outcomes

  1. Oswestry Disability Index (ODI)

    Time frame: From enrollment to the end of follow-up at 2 year

    0-100%, the higher the score, the more severe the lumbar spine dysfunction

Secondary outcomes

  1. X-ray

    Time frame: From enrollment to the end of follow-up at 2 year

    Progression of lumbar spondylolisthesis, assessed by postoperative lumbar radiography; (2) Measurement of sagittal translation, segmental angulation, and posterior opening based on postoperative standing flexion-extension radiographs

  2. Computed tomography (CT) scan

    Time frame: From enrollment to the end of follow-up at 2 year

    Assessment of bone resection area and preservation rate of the facet joint using postoperative computed tomography (CT) scans

  3. Magnetic resonance imaging (MRI)

    Time frame: From enrollment to the end of follow-up at 2 year

    Calculation of the enlargement ratio of the dural sac based on postoperative magnetic resonance imaging (MRI)

  4. Surgical complication

    Time frame: From enrollment to the end of follow-up at 2 year

    Any adverse events will be recorded to evaluate the safety of decompression using UBE for LSS with or without DS

  5. Visual analog scale (VAS) score for lower back pain

    Time frame: From enrollment to the end of follow-up at 2 year

    0-10, the higher the score, the more severe the pain

  6. Visual analog scale (VAS) score for leg pain

    Time frame: From enrollment to the end of follow-up at 2 year

    0-10, the higher the score, the more severe the pain

  7. Operative time

    Time frame: Immediately after the surgery

    Time to perform the operation

  8. Intraoperative blood loss

    Time frame: Immediately after the surgery

    B、 Blood loss during the surgery

  9. Postoperative hospital stays

    Time frame: Immediately after the discharge

    Number of days in hospital after operation

  10. Japanese Orthopaedic Association (JOA) score

    Time frame: From enrollment to the end of follow-up at 2 year

    0-29, the higher the score, the better the lumbar spine function

  11. Modified MacNab criteria

    Time frame: From enrollment to the end of follow-up at 2 year

    According to satisfaction, it is divided into four levels: excellent, good, acceptable, and poorexcellent, good, fair, and poor

  12. Improvement ratio of Visual analog scale (VAS) score for lower back pain

    Time frame: From enrollment to the end of follow-up at 2 year

    Improvement ratio= (preoperative VAS-postoperative VAS/preoperative VAS, ranging from 0-100%, the higher the score, the better the improment of symptoms

  13. Improvement ratio of Visual analog scale (VAS) score for leg pain

    Time frame: From enrollment to the end of follow-up at 2 year

    Improvement ratio= (preoperative VAS-postoperative VAS/preoperative VAS, ranging from 0-100%, the higher the score, the better the improment of symptoms

  14. Improvement ratio of Japanese Orthopaedic Association (JOA) score

    Time frame: From enrollment to the end of follow-up at 2 year

    Improvement ratio= (postoperative JOA-preoperative JOA/preoperative VAS, ranging from 0-100%, the higher the score, the better the improment of spinal function

  15. Improvement ratio of Oswestry Disability Index (ODI)

    Time frame: From enrollment to the end of follow-up at 2 year

    Improvement ratio= (preoperative ODI-postoperative ODI)/preoperative ODI, ranging from 0-100%, the higher the score, the better the improment of symptoms

  16. White blood cell count

    Time frame: From enrollment to 3 days after surgery

    White blood cell count of venous blood

  17. Percentage of neutrophils (N%)

    Time frame: From enrollment to 3 days after surgery

    The proportion of neutrophils relative to the total white blood cell count

  18. C-reactive protein level

    Time frame: From enrollment to 3 days after surgery

    The level of C-reactive protein in blood

  19. Creatine kinase level

    Time frame: From enrollment to 3 days after surgery

    The level of creatine kinase in blood

  20. Lactate dehydrogenase level

    Time frame: From enrollment to 3 days after surgery

    The level of Lactate dehydrogenase in blood

  21. Myoglobin level

    Time frame: From enrollment to 3 days after surgery

    The level of myoglobin in blood

Study contacts

Contact information is provided by the study sponsor or research team.

Sponsors and collaborators

Lead sponsor

Beijing Friendship Hospital

Other

Registry information

Official study title

Effect of Degenerative Spondylolisthesis on the Clinical Outcome of Unilateral Biportal Endoscopy for Lumbar Spinal Stenosis: a Single-center, Prospective Cohort Trial Protocol

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
May 1, 2024
Registry last updated
Jun 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.